GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Withus Pharmaceutical Co Ltd (XKRX:330350) » Definitions » Total Equity

Withus Pharmaceutical Co (XKRX:330350) Total Equity : ₩92,592 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Withus Pharmaceutical Co Total Equity?

Withus Pharmaceutical Co's total equity for the quarter that ended in Sep. 2024 was ₩92,592 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Withus Pharmaceutical Co Total Equity Historical Data

The historical data trend for Withus Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Withus Pharmaceutical Co Total Equity Chart

Withus Pharmaceutical Co Annual Data
Trend Jun19 Jun20 Dec21 Dec22 Dec23
Total Equity
52,428.81 76,759.47 80,905.22 83,036.15 90,277.97

Withus Pharmaceutical Co Quarterly Data
Sep19 Mar20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87,904.11 90,277.97 90,984.54 90,720.93 92,592.28

Withus Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Withus Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=130780.017-40502.05
=90,278

Withus Pharmaceutical Co's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=130901.631-38309.349
=92,592

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Withus Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Withus Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Withus Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
9 Dongsan-ro 12-gil, Seocho-gu, 3rd, 4th, and 5th Floors of Withers Building, Seoul, KOR
Withus Pharmaceutical Co Ltd is a pharmaceutical company. The firm is engaged in the manufacturing and selling of various medicines such as Broazette long-acting tablet, Wipina tablets, Mantini tablets, and Choline syrup among others.

Withus Pharmaceutical Co Headlines

No Headlines